Clinical Trials on Neoplasm, Plasma Cell in Germany

Total 6397 results

iOMEDICO AG
Novartis

Completed

Open Label, Single Arm Trial to Characterize Patients With Metastatic RCC Treated With Everolimus After Failure of the First VEGF-targeted Therapy (MARC-2) (MARC-2)

Metastatic Renal Cell Carcinoma | Failure of Exactly One Prior VEGF-targeted Therapy

Germany
Association of Urologic Oncology (AUO)
University Hospital, Essen

Unknown

Resection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT) (SMAT)

Renal Cell Carcinoma | Pulmonary Metastases

Germany
Novo Nordisk A/S

Completed

Combination of Recombinant Human IL-21 (rIL-21) and Sunitinib in Stage IV Renal Cell Carcinoma Patients

Renal Cell Carcinoma | Cancer

Germany, Netherlands
WiSP Wissenschaftlicher Service Pharma GmbH
Mundipharma Research GmbH & Co KG; Klinikum Leverkusen gGmbH; ribosepharm GmbH

Completed

Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia

Germany
University of Cologne

Terminated

NB2013-HR German (GPOH) / Dutch (DCOG) Trial (NB2013-HR)

Neuroblastoma

Germany
Vaximm GmbH

Completed

VXM01 Phase I Pilot Study in Patients With Operable Recurrence of a Glioblastoma

Glioblastoma

Germany
Incyte Corporation

Terminated

INCB001158 Combined With Subcutaneous (SC) Daratumumab, Compared to Daratumumab SC, in Relapsed or Refractory Multiple Myeloma

Relapsed or Refractory Multiple Myeloma

United States, Spain, Germany
University of Regensburg

Unknown

Immune Monitoring in Metastatic Melanoma

Metastatic Melanoma

Germany
Prothena Biosciences Ltd.

Completed

The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis (PRONTO)

AL Amyloidosis

United States, Spain, Australia, Germany, United Kingdom, France, Greece, Israel, Italy, Austria
Janssen-Cilag International NV

Completed

Study to Evaluate Optimized Retreatment and Prolonged Therapy With Bortezomib (OPTIMRETREAT)

Multiple Myeloma

France, Poland, Belgium, Germany, Israel, Portugal, Turkey, Finland, Sweden, Netherlands, Norway
Novartis Pharmaceuticals

Completed

Evaluate Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETs (MACS2002)

Neuroendocrine Tumors

Germany
University Hospital Erlangen

Completed

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)

Germany
Dermatologische Klinik MIT Poliklinik-Universitaetsklinikum...

Unknown

Vaccine Therapy in Treating Patients With Stage IV Melanoma

Melanoma (Skin)

Germany
European Organisation for Research and Treatment...

Terminated

Boron Neutron Capture Therapy Using Boronophenylalanine-Fructose Complex in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

Germany
Boehringer Ingelheim

Completed

GIOTRIF in First Line Therapy of Advanced NSCLC With EGFR-mutations

Carcinoma, Non-Small-Cell Lung

Germany
Goethe University

Completed

Treatment of Relapsed T-cell Acute Lymphoblastic Leukemia or T-lymphoblastic Lymphoma With MabCampath

Lymphoma, Lymphoblastic | Adult Acute Lymphocytic Leukemia T-cell

Germany
European Organisation for Research and Treatment...

Unknown

LungTech: Stereotactic Body Radiotherapy (SBRT) of Inoperable Centrally Located NSCLC (LungTech)

Non-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage II

Germany, Belgium, United Kingdom, Switzerland
University Hospital Tuebingen
AstraZeneca

Recruiting

Influence of Biopsy Technique on Moleculargenetic Tumor Characterisation in NSCLC (PROFILER)

Carcinoma, Non-Small-Cell Lung | Pathology, Molecular

Germany
Juergen Debus

Withdrawn

Effect of Timing of Tumor-Treating Fields Plus Short-Course Radiation (GERAS)

Newly Diagnosed Glioblastoma in Patients ≥70 Years

Germany
Oryx GmbH & Co. KG

Completed

Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme. (ParvOryx01)

Glioblastoma Multiforme

Germany
Ipsen

Terminated

Evaluate the Safety, Tolerability, Biodistribution and Anti Tumour Activity of 177LU-OPS201 With Companion Imaging 68Ga-OPS202 PET/CT in Previously Treated Subjects With Locally Advanced or Metastatic Cancers Expressing Somatostatin Receptor 2 (SSTR2) (SSTR2+)

Small Cell Lung Cancer and Breast Cancer

United States, Austria, France, Switzerland, Germany, United Kingdom, Belgium
University Hospital Tuebingen
Charite University, Berlin, Germany; University Hospital Heidelberg

Completed

FLuorescence Identification of Melanoma by a Multicenter Based Algorithm (FLIMMA) (FLIMMA)

Melanoma | Moles

Germany
AbbVie

Terminated

Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Lemzoparlimab With or Without Oral/IV Dexamethasone and in Combination With Oral/IV/Subcutaneous Anti-Myeloma Regimens in Adult Participants With Multiple Myeloma

Multiple Myeloma

United States, Australia, France, Germany, Israel, Japan, Spain
Georg Hess, MD
Wyeth is now a wholly owned subsidiary of Pfizer; Mundipharma Pte Ltd.

Completed

Temsirolimus, Bendamustine and Rituximab for Relapsed Follicular Lymphoma or Mantle Cell Lymphoma (BERT)

Follicular Lymphoma | Mantle Cell Lymphoma

Germany
University Hospital Erlangen

Completed

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)

Germany
University Hospital Muenster

Unknown

Anesthesia and Cancer Recurrence im Malignant Melanoma

Malignant Melanoma

Germany
Hoffmann-La Roche

Completed

AVAdeno Study: An Observational Study of First-Line Avastin (Bevacizumab) in Patients With Adenocarcinoma of the Lung

Non-Squamous Non-Small Cell Lung Cancer

Germany
University of Cologne

Unknown

Changes in the Gut Microbiota of Patients Undergoing Allogeneic Stem Cell Transplantation (COLLECT) (COLLECT)

Acute Myeloid Leukemia | Allogeneic Hematopoietic Stem Cell Transplantation | Stem Cell Transplant Complications | Graft-versus-host-disease

Germany
Sanofi

Completed

Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Head and Neck Neoplasms | Neoplasm Metastasis | Neoplasm Recurrence, Local

Russian Federation, United States, Canada, Germany, Hungary, Italy, South Africa, Argentina, Uruguay, Austria, Switzerland, Israel, Belgium, France, Australia, Brazil, Greece, Guadeloupe, Réunion, Spain
University Hospital Tuebingen

Recruiting

Multi Peptide Vaccination With XS15 in Addition to Standard Postoperative Radiation Therapy and Temozolomide Chemotherapy in Newly Diagnosed Glioblastoma (GLIO-XS15)

Glioblastoma Multiforme of Brain

Germany
Technical University of Munich
Helmholtz Zentrum München

Recruiting

Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma (GlioCave/NOA17)

Glioblastoma

Germany
University of Erlangen-Nürnberg Medical School

Completed

Immunophenotyping From Blood of Patients With Malignant Gliomas

Glioblastoma Multiforme | Anaplastic Astrocytoma

Germany
Prof. Dr. Juergen Wolf
Charite University, Berlin, Germany; University Hospital, Essen; Goethe University and other collaborators

Recruiting

National Network Genomic Medicine Lung Cancer, Germany (nNGM)

Carcinoma, Non-Small-Cell Lung

Germany
Boston Scientific Corporation

Terminated

Study of Intraparenchymal Therapy With Irinotecan Drug Eluting Beads as Adjunct to Recurrent Surgically Resectable High Grade Glioma (IDEB-glioma)

Glioma

France, Germany
Vaximm GmbH
Pfizer; Merck KGaA, Darmstadt, Germany

Active, not recruiting

VXM01 Plus Avelumab Combination Study in Progressive Glioblastoma

Recurrent Glioblastoma

Germany
Central European Society for Anticancer Drug Research

Completed

Sequential Therapy in Metastatic Renal Cell Carinoma (BERAT)

Metastatic Renal Cell Carcinoma

Germany
Hasumi International Research Foundation

Active, not recruiting

IKKb-matured, RNA-loaded Dendritic Cells for Metastasised Uveal Melanoma

Melanoma, Uveal Metastatic

Germany
Celgene

Completed

A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma

Multiple Myeloma

Spain, United Kingdom, Switzerland, Australia, Israel, Italy, Poland, France, Belgium, Ireland, Austria, Germany, Ukraine, Greece, Sweden
Amgen

Completed

A Study of Carfilzomib vs Best Supportive Care in Subjects With Relapsed and Refractory Multiple Myeloma (FOCUS)

Multiple Myeloma

France, Poland, United Kingdom, Belgium, Germany, Spain, Israel, Serbia, Australia, Greece, Korea, Republic of, Russian Federation, Hungary, Sweden, Austria, Slovakia, Italy, Czechia, New Zealand
Bayer

Withdrawn

Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma

Multiple Myeloma

Belgium, Spain, Korea, Republic of, Taiwan, United States, Australia, Germany, Israel, Italy, Greece, Canada
University Hospital Heidelberg

Recruiting

Glioblastoma Radiotherapy Using IMRT or Proton Beams (GRIPS)

Glioblastoma

Germany
Boehringer Ingelheim

Recruiting

DAREON™-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With Topotecan

Small Cell Lung Carcinoma (SCLC)

United Kingdom, Germany, France, Poland
University of Regensburg

Completed

Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma (RIST-rNB-2011)

Neuroblastoma Recurrent

Germany
Head and Neck Cancer International Group

Completed

Ascertaining the Radiologic Prognostic Importance of Extranodal Extension on Imaging (iENE) in Head and Neck Cancer (EPIC-iENE DATA)

Head and Neck Squamous Cell Carcinoma | Extranodal Extension | Human Papilloma Virus Related Carcinoma

Switzerland, United Kingdom, United States, Germany, Australia, France, Spain, Denmark
Hoffmann-La Roche

Completed

Safety and Efficacy Study of Avastin in Locally Advanced Metastatic or Recurrent Non-small Lung Cancer (NSLC) Participants

Non-Squamous Non-Small Cell Lung Cancer

Germany
Ruhr University of Bochum

Completed

Immunohistochemical Expression Patterns of microRNA Processing Enzyme Dicer in Cutaneous Malignant Melanoma, Benign and Dysplastic Melanocytic Naevi

Malignant Melanoma | Naevi

Germany
German Cancer Research Center
Heidelberg University

Completed

Exercise Study in Patients With Lung Cancer (POSITIVE)

Non Small Cell Lung Cancer

Germany
University Hospital Tuebingen

Completed

Vegetative Monitoring During Brainstem-associated Surgery

Brain Tumor, Recurrent | Vestibular Schwannoma | Brainstem Glioma | Brainstem Neoplasm

Germany
Novartis Pharmaceuticals

Completed

Safety of Everolimus and Pemetrexed in Lung Cancer Patients

Non Small Cell Lung Cancer

Belgium, Australia, Germany
Takeda

Active, not recruiting

A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant

Multiple Myeloma | Autologous Stem Cell Transplant

United States, Spain, Australia, Czechia, Hungary, Taiwan, Italy, Denmark, Portugal, Singapore, Israel, Canada, France, Belgium, United Kingdom, Germany, Japan, Austria, Netherlands, Korea, Republic of, Poland, Greece, Colombia, Sweden, South Africa and more

Clinical Trials on Neoplasm, Plasma Cell in Germany

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations